COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,579 Articles (22,415 medRxiv, 8,164 bioRxiv)

Most recent first Previous |  Page 1271: Articles 12701-12710  | Next

Community Mobility and COVID-19 Dynamics in Jakarta, Indonesia
Nanda, R. O., Nursetyo, A. A., Ramadona, A. L., Imron, M. A., Fuad, A., Setyawan, A., Ahmad, R. A.
10.1101/2021.07.24.21261016 — Posted: 2021-07-29
Outbreak of P.3 (Theta) SARS-CoV-2 emerging variant of concern among food service workers in Louisiana
Rose, R., Nolan, D. J., LaFleur, T. M., Lamers, S. L.
10.1101/2021.07.28.21259040 — Posted: 2021-07-29
Covid-19 Associated Hepatitis in children (CACH) during the second wave of SARS-CoV-2 infections in Central India: Is it a complication or transient phenomenon.
Rawat, S. K., Asati, A. a., Jain, A., Ratho, R. K.
10.1101/2021.07.23.21260716 — Posted: 2021-07-29 Discussion: Onsite
Effectiveness of BNT162b2 and ChAdOx1 vaccines against symptomatic COVID-19 among Healthcare Workers in Kuwait: A retrospective cohort study
Alali, W. Q., Ali, L. A., AlSeaidan, M., Al-Rashidi, M.
10.1101/2021.07.25.21261083 — Posted: 2021-07-29
Prognostic accuracy of triage tools for adults with suspected COVID-19 in a pre-hospital setting: an observational cohort study
Marincowitz, C., Sutton, L., Stone, T., Pilbery, R., Campbell, R., Thomas, B., Turner, J., Bath, P., Bell, F., Biggs, K., Hasan, M., Hopfgartner, F., Mazumdar, S., Petrie, J., Goodacre, S.
10.1101/2021.07.27.21261031 — Posted: 2021-07-29
Laboratory Study of Physical Barrier Efficiency for Worker Protection against SARS-CoV-2 while Standing or Sitting
Bartels, J., Estill, C. F., Chen, I.-C., Neu, D.
10.1101/2021.07.26.21261146 — Posted: 2021-07-29
Tracking Cryptic SARS-CoV-2 Lineages Detected in NYC Wastewater
Smyth, D. S., Trujillo, M., Gregory, D. A., Cheung, K., Gao, A., Graham, M., Guan, Y., Guldenpfennig, C., Hoxie, I., Kannoly, S., Kubota, N., Lyddon, T. D., Markman, M., Rushford, C., San, K. M., Sompanya, G., Spagnolo, F., Suarez, R., Teixeiro, E., Daniels, M., Johnson, M., Dennehy, J. J.
10.1101/2021.07.26.21261142 — Posted: 2021-07-29
Reactive vaccination of workplaces and schools against COVID-19
Faucher, B., Assab, R., Roux, J., Levy-Bruhl, D., Tran Kiem, C., Cauchemez, S., Zanetti, L., Colizza, V., Boëlle, P.-Y., Poletto, C.
10.1101/2021.07.26.21261133 — Posted: 2021-07-29
The human nose organoid respiratory virus model: an ex-vivo human challenge model to study RSV and SARS-CoV-2 pathogenesis and evaluate therapeutics
Rajan, A., Weaver, A. M., Alosio, G. M., Jelinski, J., Johnson, H. L., Venable, S. F., McBride, T., Aideyan, L., Piedra, F.-A., Ye, X., Melicoff-Portillo, E., Yerramilli, M. R. K., Zeng, X.-L., Mancini, M. A., Stossi, F., Maresso, A. W., Kotkar, S. A., Estes, M. K., Blutt, S., Avadhanula, V., Piedra, P. A.
10.1101/2021.07.28.453844 — Posted: 2021-07-28
BRET-based self-cleaving biosensors for SARS-CoV-2 3CLpro Inhibitor Discovery
Hou, N., Peng, C., Zhang, L., Zhu, Y., Hu, Q.
10.1101/2021.07.28.454072 — Posted: 2021-07-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).